Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Stockholders’ Equity (Deficit), beginning balances at Dec. 31, 2019	$ (72,970)	$ 1	$ 6,054	$ (39)		$ (79,025)	$ 39
Redeemable Convertible Preferred Stock, beginning balances (in shares) at Dec. 31, 2019	7,375,631
Redeemable Convertible Preferred Stock, beginning balances at Dec. 31, 2019	$ 102,980
Stockholders’ Equity (Deficit), beginning balances (in shares) at Dec. 31, 2019		5,178,955
Accounting Standards Update [Extensible List]	Accounting Standard Update ("ASU") 2018-07
Issuance of redeemable convertible preferred stock, net of $3,138 of issuance cost	$ 72,468
Issuance of redeemable convertible preferred stock, net of $3,138 of issuance cost (in shares)	4,200,353
Conversion of redeemable convertible preferred stock into common stock	$ 175,448	$ 1	175,447
Conversion of redeemable convertible preferred stock into common stock (in shares)		11,575,984
Conversion of redeemable convertible preferred stock into common stock	$ (175,448)
Conversion of redeemable convertible preferred stock into common stock (in shares)	(11,575,984)
Issuance of common stock upon initial public offering, net of issuance cost	$ 204,713	$ 1	204,712
Issuance of common stock upon initial public offering, net of issuance cost (in shares)		9,660,000
Issuance of common stock upon exercise of stock options	857		857
Issuance of common stock upon exercise of stock options (in shares)		267,044
Stock-based compensation expense	4,984		4,984
Vesting of common stock warrants issued for services	48		48
Net loss	(56,693)					(56,693)
Stockholders’ Equity (Deficit), ending balances at Dec. 31, 2020	$ 256,387	$ 3	392,063			(135,679)
Redeemable Convertible Preferred Stock, ending balances (in shares) at Dec. 31, 2020	0
Stockholders’ Equity (Deficit), ending balances (in shares) at Dec. 31, 2020		26,681,983
Issuance of common stock upon exercise of stock options and warrants	$ 3,905		3,905
Issuance of common stock upon exercise of stock options and warrants (in shares)		646,417
Issuance of common stock upon initial public offering, net of issuance cost	$ 115,090		115,090
Issuance of common stock upon initial public offering, net of issuance cost (in shares)		4,875,715
Issuance of common stock upon exercise of stock options (in shares)	563,387
Issuance of common stock warrant	$ 1,146		1,146
Stock-based compensation expense	13,799		13,799
Issuance of common stock - 2020 ESPP	433		433
Issuance of common stock - 2020 ESPP (in shares)		20,409
Vesting of common stock warrants issued for services	87		87
Gross unrealized loss on marketable securities	(423)				$ (423)
Net loss	(71,317)				(71,317)	(71,317)
Stockholders’ Equity (Deficit), ending balances at Dec. 31, 2021	$ 319,107	$ 3	$ 526,523		$ (423)	$ (206,996)
Redeemable Convertible Preferred Stock, ending balances (in shares) at Dec. 31, 2021	0
Stockholders’ Equity (Deficit), ending balances (in shares) at Dec. 31, 2021		32,224,524